Fresenius | FRE - Operating Profit

Stock Price
46.92
Daily Change
0.10 0.21%
Monthly
-9.98%
Yearly
17.54%
Q1 Forecast
45.46

Fresenius reported EUR713M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Akzo Nobel EUR 217M 80M Dec/2025
Alcon AG USD 313M 19M Dec/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
BASF EUR -175M 668M Dec/2025
Bayer EUR 1.11B 1.65B Dec/2025
Beiersdorf EUR 504M 312M Dec/2025
DaVita Healthcare Partners USD 584.2M 88.6M Dec/2025
Demant DKK 2.09B 224M Dec/2025
E.ON EUR 1.06B 816M Dec/2025
Essilor EUR 1.38B 626M Dec/2025
Fresenius EUR 713M 139M Dec/2025
Fresenius Medical Care EUR 663M 213.06M Dec/2025
Getinge SEK 1.08B 900M Dec/2024
Givaudan CHF 364.5M 165.5M Jun/2024
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GN Store Nord DKK 570M 230M Dec/2025
GRIFOLS EUR 275.38M 76.74M Dec/2025
Hikma Pharmaceutical USD 348M 161M Dec/2025
Lonza CHF 430M 104M Dec/2024
Merck EUR 474M 738M Dec/2025
Novartis USD 4.5B 363M Sep/2025
Philips EUR 719M 390M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
RWE EUR 577M 310M Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Smith & Nephew USD 440M 50M Dec/2025